At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 112 enrolled
Drug / intervention
Brinzolamide 1.0% + Timolol 0.5% ophthalmic suspension +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Open-Angle Glaucoma or Ocular Hypertension
In Brief
A Phase 4 clinical trial evaluating Brinzolamide 1.0% + Timolol 0.5% ophthalmic suspension and Dorzolamide 2.0% + Timolol 0.5% ophthalmic solution for Open-Angle Glaucoma and Ocular Hypertension. Completed, enrolled 112 participants.
Detailed Summary
The purpose of this study was to assess patient preference regarding ocular comfort of AZARGA® compared to COSOPT® after one week instillation of each study medication.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpen-Angle Glaucoma, Ocular Hypertension
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2011
Enrollment StartSep 2011
Primary CompletionOct 2012
TodayJul 2026
First PostedApr 21, 2011
Enrollment StartSep 1, 2011
Primary CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 15.2 years ago
Interventions
Brinzolamide 1.0% + Timolol 0.5% ophthalmic suspensiondrug
Dorzolamide 2.0% + Timolol 0.5% ophthalmic solutiondrug